Recent Quotes

My Watchlist

Indicators

Currencies

International

Treasuries

VanEck Pharmaceutical ETF (NQ:PPH)

99.25 +0.02 (+0.02%)

Streaming Delayed Price Updated: 1:13 PM EST, Nov 19, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	93,767
Open	99.36
Bid (Size)	99.22 (600)
Ask (Size)	99.26 (200)
Prev. Close	99.23
Today's Range	98.90 - 99.61
52wk Range	77.67 - 100.46
Shares Outstanding	N/A
Dividend Yield	1.58%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Hedge Funds Snap Up Eli Lilly, United Healthcare, And More, Putting Healthcare ETFs Back In The Spotlight ↗

November 17, 2025

With funds buying Eli Lilly, UNH, and other pharma giants, healthcare ETFs can emerge as key beneficiaries of a broader defensive rotation.

Via Benzinga

Eli Lilly Supremacy: How One Stock Is Dictating Performance Across Pharma ETFs ↗

November 15, 2025

A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed to one stock than they realize.

Via Benzinga

Performance

YTD	+15.0%	+15.0%
1 Month	+7.4%	+7.4%
3 Month	+12.7%	+12.7%
6 Month	+13.9%	+13.9%
1 Year	+14.6%	+14.6%

More News

Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗

November 12, 2025

Via Benzinga

AstraZeneca Q2 Beats On Cancer Drug Sales, Maintains Guidance — Shares Rise Premarket As Retail Cheers ↗

July 29, 2025

Via Stocktwits

Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided ↗

July 21, 2025

Via Stocktwits

Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain ↗

October 30, 2025

Via Benzinga

Trump's Weight-Loss Drug Push May Put These ETFs On A Diet ↗

October 17, 2025

Via Benzinga

Drug Stocks Just Had Their Best Week in 2 Decades. Should You Invest? ↗

October 13, 2025

Via The Motley Fool

Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗

September 29, 2025

Via Benzinga

Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗

September 29, 2025

Via Benzinga

Pharma Tariffs Back In Spotlight On New Trump Threat ↗

September 26, 2025

Via Investor's Business Daily

Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗

September 08, 2025

Via Benzinga

Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' ↗

August 01, 2025

Via Benzinga

Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' ↗

July 16, 2025

Via Benzinga

FDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: Report ↗

July 11, 2025

Via Stocktwits

Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗

July 11, 2025

Via Benzinga

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗

June 20, 2025

Via Benzinga

FDA Aims To Reduce Drug Application Review Time With New Voucher Program ↗

June 17, 2025

Via Stocktwits

Here's How Trump Plans To Tackle Drug Prices, And Why It Might Not Work ↗

May 20, 2025

Via Investor's Business Daily

Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion ↗

May 19, 2025

Via Benzinga

Are Your Health Care ETFs Safe? Trump's New Policies May Trigger Shockwaves Across Pharma Stocks ↗

May 08, 2025

Via Benzinga

Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report ↗

April 28, 2025

Via Stocktwits

Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies ↗

April 11, 2025

Via Benzinga

Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises ↗

February 19, 2025

Via Stocktwits

VanEck Announces Year-End Distributions for VanEck Equity ETFs

December 20, 2024

From VanEck

Via Business Wire

Frequently Asked Questions

Is VanEck Pharmaceutical ETF publicly traded?

Yes, VanEck Pharmaceutical ETF is publicly traded.

What exchange does VanEck Pharmaceutical ETF trade on?

VanEck Pharmaceutical ETF trades on the Nasdaq Stock Market

What is the ticker symbol for VanEck Pharmaceutical ETF?

The ticker symbol for VanEck Pharmaceutical ETF is PPH on the Nasdaq Stock Market

What is the current price of VanEck Pharmaceutical ETF?

The current price of VanEck Pharmaceutical ETF is 99.25

When was VanEck Pharmaceutical ETF last traded?

The last trade of VanEck Pharmaceutical ETF was at 11/19/25 01:13 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.